Explore our brands

Our brands bring together the industry's most influential leaders and scientific experts, inspiring thought-provoking and insightful content that offers a unique perspective on R&D trends and challenges.
Contact
AI, Machine Learning & Computational Drug Design | Q&As & Interviews

Interview with Thierry Dorval, Head of Data Sciences & Data Management at Servier

Edited by Tom Cohen | 30 March 2023
Thierry Dorval from Servier talks about AI methods, their limitations, and how they are changing the way that data is viewed in the pharmaceutical industry.
https://youtu.be/G3hvnbpDKuU

Visit our Discovery Portal to learn more about the latest research into drug design, development, and more. If you’d like to register your interest for Oxford Global‘s upcoming conference, Organ Modelling 2023, click here.

Get your weekly dose of industry news?here?and keep up to date with the latest?‘Industry Spotlight’ posts.?For other Discovery content, please visit the?Discovery Content Portal.

Related Resources

Novo Nordisk Foundation and NVIDIA to Launch a State-of-the-Art National AI Research Centre

Novo Nordisk and NVIDIA join forces to build an AI supercomputer which will be housed in Denmark's national centre for AI innovation.
Read More

AI-driven High Throughput Screening for Targeted Drug Discovery

Artificial Intelligence (AI) has significantly transformed high throughput screening (HTS) in drug discovery, increasing efficiency, accuracy, and predictive capabilities in early drug development stages. This research highlights AI's integration into HTS processes, showcasing improved outcomes in hit identification, assay optimization, and target validation, thus accelerating and refining the search for new medications.
Read More

Related Online Activities

Join the conversation with our upcoming Monthly Science Exchanges and Webinars:
20/03/24
The Design of Novel Drugs with Generative AI
28/03/24
Generative AI and Large Language Models for Quantitative and Systems Pharmacology